© 2021 MJH Life Sciences and Urology Times. All rights reserved.
© 2021 MJH Life Sciences™ and Urology Times. All rights reserved.
October 29, 2020
Investigators reported that the treatment-emergent adverse event results showed combination tamsulosin and mirabegron was well-tolerated and had a favorable safety profile.
September 23, 2020
The Optilume drug-coated balloon catheter system has been approved for use in European patients with urethral strictures.
August 06, 2020
Julia Beth Finkelstein, MD, MPH, CPPS, and colleagues evaluated the safety and costs associated with telemedicine appointments for pediatric urologic patients.
August 03, 2020
The drug-coated balloon catheter system is being compared with a sham device in a double-blinded randomized trial.
July 30, 2020
Minimally invasive water vapor thermal therapy offers rapid improvements in LUTS, QoL, and flow rate that remain durable to 5 years in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
July 23, 2020
The study compared the 2 procedures over 24 months of follow-up.
July 22, 2020
Retreatment rates were low with both aquablation and transurethral resection of the prostate.
July 21, 2020
In this interview, Jeffrey Weiss, MD, also describes “most exciting area in nocturia research.”
July 14, 2020
Significant improvements in BPH-related lower urinary tract symptoms were observed with the system.
July 10, 2020
Steven A. Kaplan, MD, explains the updates in the AUA 2020 guideline on lower urinary tract symptoms secondary to benign prostatic hyperplasia.